                         SEQUENCE LISTING

<110>  Cybrexa 2, Inc.
 
<120>  DOSING REGIMENS OF PEPTIDE CONJUGATES OF TOPOISOMERASE I 
       INHIBITORS

<130>  43236-0019WO1

<150>  US 63/181,640
<151>  2021-04-29

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  28
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide

<400>  1

Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe Pro 
1               5                   10                  15      


Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp Cys Gly 
            20                  25              


<210>  2
<211>  35
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide

<400>  2

Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala Asp 
            20                  25                  30          


Glu Cys Gly 
        35  


<210>  3
<211>  32
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide

<400>  3

Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe Pro 
1               5                   10                  15      


Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp Asp Ala Asp Glu Cys Gly 
            20                  25                  30          


<210>  4
<211>  39
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide

<400>  4

Ala Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr Lys Cys Gly 
        35                  


<210>  5
<211>  37
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide

<400>  5

Ala Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr Cys 
        35          


